症状膝关节骨关节炎与2型糖尿病患者的目标血糖控制之间的关联
Lauren K King1,2, Alanna Weisman1,3, Baiju R Shah1,4
1University of Toronto, Toronto, ON, Canada.
Arthritis care & research
|December 18, 2025
概括
患有2型糖尿病和疼痛膝关节关节炎的人不太可能达到目标的血糖控制. 这一发现凸显了这种患者群体患糖尿病相关并发症的风险增加.
科学领域:
- 类风湿病学 类风湿病学
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 膝关节骨关节炎 (OA) 在2型糖尿病 (T2DM) 患者中很普遍.
- 在T2DM中OA与糖尿病并发症的风险更高有关.
- 了解T2DM中OA与血糖控制的联系至关重要.
研究的目的:
- 调查T2DM患者的症状膝关节OA和血糖控制之间的关联.
- 探索膝关节OA疼痛和行走困难如何影响血糖控制.
主要方法:
- 在加拿大对351名T2DM患者 (年龄≥45) 的横截面研究.
- 根据NICE标准定义的膝关节OA;目标血糖控制HbA1c ≤7.0%.
- 多变量逻辑回归调整为年龄,性别,教育和BMI.
主要成果:
- 28.5%的人患有膝关节骨质炎,43.9%的人达到血糖目标.
- 仅膝关节OA在调整后与目标血糖控制没有显著关联.
- 疼痛膝关节OA (≥20/100) 与目标血糖控制 (aOR 0.58) 有显著的负相关性.
结论:
- 在T2DM患者中,疼痛的膝盖OA与较差的血糖控制有关.
- 这个子组面临糖尿病并发症的风险较高.
- 对T2DM中疼痛性OA的临床关注是改善糖尿病管理的必要条件.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
4.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Diabetes: Symptoms, Diagnosis, and Complications
2.0K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.0K
Diabetes: Management and Pharmacotherapy
848
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
848
Diabetes Mellitus: Overview and Type I Subtype
4.8K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.8K
Carbohydrate Metabolism
13.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.7K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
505
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
505


